Why Did Piper Sandler Give Intra-Cellular Therapies Inc (ITCI) Stock Overweight Rating?
Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 and touched a low of $126.
Hosted on MSN5h
Piper Sandler Upgrades Travelers Companies (TRV)Fintel reports that on January 24, 2025, Piper Sandler upgraded their outlook for Travelers Companies (NYSE:TRV) from Neutral ...
That's changed: Lyons is acknowledged heir apparent at a giant fintech where he'll become CEO by July at the latest.
Piper Sandler reiterated an Overweight rating and $670 price target on Meta Platforms (META) after CEO Mark Zuckerberg said in a Facebook post ...
Pets insurance company Trupanion (NASDAQ:TRUP) was upgraded at Piper Sandler on improving investor sentiment and several ...
Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Piper Sandler analyst Anna Andreeva maintained a Hold rating on Deckers Outdoor (DECK – Research Report) today and set a price target of ...
LONDON, January 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to its energy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback